| Role of gut commensal microflora in the development of experimental autoimmune encephalomyelitis J Ochoa-Repáraz, DW Mielcarz, LE Ditrio, AR Burroughs, DM Foureau, ... The Journal of Immunology 183 (10), 6041-6050, 2009 | 628 | 2009 |
| Extramedullary multiple myeloma M Bhutani, DM Foureau, S Atrash, PM Voorhees, SZ Usmani Leukemia 34 (1), 1-20, 2020 | 182 | 2020 |
| TLR9 is required for the gut-associated lymphoid tissue response following oral infection of Toxoplasma gondii LA Minns, LC Menard, DM Foureau, S Darche, C Ronet, DW Mielcarz, ... The Journal of Immunology 176 (12), 7589-7597, 2006 | 171 | 2006 |
| Drug-induced liver injury with autoimmune features AS deLemos, DM Foureau, C Jacobs, W Ahrens, MW Russo, ... Seminars in liver disease 34 (02), 194-204, 2014 | 158 | 2014 |
| B cells amplify IFN-γ production by T cells via a TNF-α-mediated mechanism LC Menard, LA Minns, S Darche, DW Mielcarz, DM Foureau, D Roos, ... The Journal of Immunology 179 (7), 4857-4866, 2007 | 130 | 2007 |
| Structure and function of proteins in hydrated choline dihydrogen phosphate ionic liquid KD Weaver, RM Vrikkis, MP Van Vorst, J Trullinger, R Vijayaraghavan, ... Physical Chemistry Chemical Physics 14 (2), 790-801, 2012 | 109 | 2012 |
| Comparative analysis of portal hepatic infiltrating leucocytes in acute drug-induced liver injury, idiopathic autoimmune and viral hepatitis DM Foureau, TL Walling, V Maddukuri, W Anderson, K Culbreath, ... Clinical & Experimental Immunology 180 (1), 40-51, 2015 | 102 | 2015 |
| Profiles of serum cytokines in acute drug-induced liver injury and their prognostic significance NM Steuerwald, DM Foureau, HJ Norton, J Zhou, JC Parsons, ... PloS one 8 (12), e81974, 2013 | 90 | 2013 |
| Hepatotoxicity associated with the use of anti-TNF-α agents JB French, M Bonacini, M Ghabril, D Foureau, HL Bonkovsky Drug safety 39 (3), 199-208, 2016 | 81 | 2016 |
| TLR9-dependent induction of intestinal α-defensins by Toxoplasma gondii DM Foureau, DW Mielcarz, LC Menard, J Schulthess, C Werts, V Vasseur, ... The Journal of Immunology 184 (12), 7022-7029, 2010 | 79 | 2010 |
| Downregulation of IL-17 and IL-6 in the central nervous system by glatiramer acetate in experimental autoimmune encephalomyelitis S Begum-Haque, A Sharma, IR Kasper, DM Foureau, DW Mielcarz, ... Journal of neuroimmunology 204 (1-2), 58-65, 2008 | 78 | 2008 |
| Profiles of mi RNA s in serum in severe acute drug induced liver injury and their prognostic significance MW Russo, N Steuerwald, HJ Norton, WE Anderson, D Foureau, ... Liver international 37 (5), 757-764, 2017 | 55 | 2017 |
| Silibinin (Milk Thistle) potentiates ethanol-dependent hepatocellular carcinoma progression in male mice E Brandon-Warner, AL Eheim, DM Foureau, TL Walling, LW Schrum, ... Cancer letters 326 (1), 88-95, 2012 | 55 | 2012 |
| Phase II study of pembrolizumab in combination with doxorubicin in metastatic and unresectable soft-tissue sarcoma MB Livingston, MH Jagosky, MM Robinson, WA Ahrens, JH Benbow, ... Clinical Cancer Research 27 (23), 6424-6431, 2021 | 38 | 2021 |
| Cytokine profiles in acute liver injury—Results from the US Drug-Induced Liver Injury Network (DILIN) and the Acute Liver Failure Study Group HL Bonkovsky, HX Barnhart, DM Foureau, N Steuerwald, WM Lee, J Gu, ... PLoS One 13 (10), e0206389, 2018 | 32 | 2018 |
| miR‐122 decreases HCV entry into hepatocytes through binding to the 3′ UTR of OCLN mRNA H Sendi, M Mehrab‐Mohseni, DM Foureau, S Ghosh, TL Walling, ... Liver International 35 (4), 1315-1323, 2015 | 30 | 2015 |
| In Vitro Assessment of Choline Dihydrogen Phosphate (CDHP) as a Vehicle for Recombinant Human Interleukin-2 (rhIL-2) DM Foureau, RM Vrikkis, CP Jones, KD Weaver, DR MacFarlane, JC Salo, ... Cellular and molecular bioengineering 5, 390-401, 2012 | 27 | 2012 |
| Peripheral immunotype correlates with minimal residual disease status and is modulated by immunomodulatory drugs in multiple myeloma M Bhutani, D Foureau, Q Zhang, M Robinson, AS Wynn, NM Steuerwald, ... Biology of Blood and Marrow Transplantation 25 (3), 459-465, 2019 | 21 | 2019 |
| Ex vivo efficacy of BCMA‐bispecific antibody TNB‐383B in relapsed/refractory multiple myeloma DM Foureau, M Bhutani, M Robinson, F Guo, D Pham, B Buelow, ... EJHaem 1 (1), 113-121, 2020 | 15 | 2020 |
| T618I CSF3R mutations in chronic neutrophilic leukemia induce oncogenic signals through aberrant trafficking and constitutive phosphorylation of the O-glycosylated receptor form A Price, LJ Druhan, A Lance, G Clark, CG Vestal, Q Zhang, D Foureau, ... Biochemical and Biophysical Research Communications 523 (1), 208-213, 2020 | 14 | 2020 |
